Pentoxifylline
7 NDCs across 4 manufacturers|7 Generic,0 Brand
Pentoxifylline is used to treat brain ischemia, diabetic angiopathies, diabetic neuropathies, gangrene, vasculogenic impotence and intermittent claudication, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Aug 30, 1984, and the first generic was approved Jul 8, 1997. FDA's Orange Book lists 4 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $12 million on Pentoxifylline across 362,000 claims for 89,000 beneficiaries.
Pentoxifylline is available as 7 NDCs from 4 manufacturers (7 generic, 0 brand), with NADAC prices from $0.23 to $0.23 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
7
7G / 0B
Manufacturers
4
competing in market
Price Spread
$0.23 – $0.23
per EA
7d Activity
avg -1.3% WoW · of 7 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Rising Pharma Holdings Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Blood Viscosity Reducer class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
4 manufacturers producing PENTOXIFYLLINE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
PENTOXIFYLLINE ER 400 MG TAB | $0.2273 per EA | -1.31% |
PENTOXIFYLLINE ER 400 MG TAB | $0.2273 per EA | -1.31% |
PENTOXIFYLLINE ER 400 MG TAB | $0.2273 per EA | -1.31% |
PENTOXIFYLLINE ER 400 MG TAB | $0.2273 per EA | -1.31% |
PENTOXIFYLLINE ER 400 MG TAB | $0.2273 per EA | -1.31% |
PENTOXIFYLLINE ER 400 MG TAB | $0.2273 per EA | -1.31% |
PENTOXIFYLLINE ER 400 MG TAB | $0.2273 per EA | -1.31% |
Frequently Asked Questions
What is Pentoxifylline used to treat?
Pentoxifylline is used to treat brain ischemia, diabetic angiopathies, diabetic neuropathies, gangrene, vasculogenic impotence and intermittent claudication, per the National Library of Medicine's MED-RT classification.
When did Pentoxifylline become available as a generic?
FDA approved the first generic Pentoxifylline (ANDA) on Jul 8, 1997. The Orange Book currently lists 4 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Pentoxifylline?
In 2024, Medicare Part D spent $12 million on Pentoxifylline across 362,000 claims for 89,000 beneficiaries.
How many Pentoxifylline products are on the market?
The Pentoxifylline drug market contains 7 NDCs from 4 manufacturers — 7 generic and 0 brand products.
What is the price range for Pentoxifylline?
NADAC reference prices for Pentoxifylline range from $0.2273 to $0.2273 per EA.
Which manufacturers make Pentoxifylline?
4 manufacturers list Pentoxifylline in NADAC. Ranked by number of NDCs, the largest are Rising Pharma Holdings Inc. (2), Apotex Corp. (2), ANI Pharmaceuticals, Inc. (2), Major Pharmaceuticals (1).
How has the price of Pentoxifylline changed recently?
Over the past 7 days, 0 Pentoxifylline NDCs rose and 7 fell, with a market-wide average change of -1.3%.